Clinical registry metadata as a hidden bottleneck in AI-driven drug discovery: a computational audit of translational phase data in glioma research
Iryna Oliynyk · 2026
Read Clinical registry metadata as a hidden bottleneck in AI-driven drug discovery: a computational audit of translational phase data in glioma research by Iryna Oliynyk (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13550597.txt.
Description
Iryna Oliynyk published a 2026 audit arguing that sloppy clinical trial records quietly undermine computer-driven drug discovery for glioma, a brain tumor. She examined 2,357 glioma-related records held in the World Health Organization trial registry at extraction in January 2026. A Python pipeline sorted phase labels into missing, not applicable, and inconsistent entries, and two new indices summarized completeness and trial maturity.
Phase information turned out badly degraded, with many records lacking labels a machine could read. Study-type fields were nearly complete yet used fragmented wording, so real trial designs fit poorly into the classic phase scheme. Oliynyk concludes that checking registry meaning, not just filling fields, must come before such data train or judge discovery algorithms.
Catalog record
| CREATOR | Iryna Oliynyk |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57809 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |